w/The Street Medical Reporter® shows PBIO, CEOS, KAVL, IPA

The Street Medical Reporter® shows CEOS, KAVL, IPA 

Pressure BioSciences (OTCMKTS:PBIO) has been a company that has been in considerable focus among a number of investors over the course of the past months and it is easy to see why. First of all, the company is involved in the development of pressure based instruments that can be deployed across a range of industries and that has already made it an interesting company for many investors.

However, it is the company’s Ultra Shear Technology (UST) platform that could be the secret sauce of its growth in the coming years. A study that was recently released by the Ohio State University has noted that the UST platform offers unique capabilities which could help in the perfect formulation as well as processing when it comes to plant-based beverages.

In this context, it is important to keep in mind that the plant-based protein drinks market is growing at a remarkable rate and it is expected that by the time 2027 comes along, it will be a market worth as much as $41 billion. I

n the paper from researchers at Ohio State University it was noted that the UST platform could actually be the key to creating sustainable as well as cost-effective alternative foods. In the paper, it was noted that the UST platform provides the wherewithal by way of which proteins from plants could be added to dairy resources.

This is a paper that demonstrated the fact that the UST platform from the company could indeed be a key component of a rapidly growing industry and hence, it could well be something that is looked into seriously by investors.

At this point in time, it may be a good idea for investors to consider adding the stock to their watch lists and watch for any action in the Pressure BioSciences stock.

The Street Medical Reporter® shows a list of companies in this stock classification.  See More companies now… The Street Medical Reporter®